Abstract
Aptamers selected from a large random sequence pool are oligonucleic acid or peptide molecules that bind to a specific target molecule with high affinity and sensitivity. Targets range from small molecules to proteins and peptides, even tissue or cells. As such, aptamers have captured the attention of scientists actively developing technologies for diverse biomedical applications. Particularly, when functionalized with nanomaterials, aptamers offer properties for both biomedical and bioanalytical applications. In this review, these features and properties are discussed with particular emphasis on the use of aptamer-based biosensor/detection platforms.
Keywords: Aptamer, biological analysis, cancer cells, nanomaterials, SELEX
Current Molecular Medicine
Title:Development of Aptamer-Based Nanomaterials for Biological Analysis
Volume: 13 Issue: 4
Author(s): Y. Pu, H. Liu, B. Liu, J. Liao, J. Liu, Z. Zhao and W. Tan
Affiliation:
Keywords: Aptamer, biological analysis, cancer cells, nanomaterials, SELEX
Abstract: Aptamers selected from a large random sequence pool are oligonucleic acid or peptide molecules that bind to a specific target molecule with high affinity and sensitivity. Targets range from small molecules to proteins and peptides, even tissue or cells. As such, aptamers have captured the attention of scientists actively developing technologies for diverse biomedical applications. Particularly, when functionalized with nanomaterials, aptamers offer properties for both biomedical and bioanalytical applications. In this review, these features and properties are discussed with particular emphasis on the use of aptamer-based biosensor/detection platforms.
Export Options
About this article
Cite this article as:
Pu Y., Liu H., Liu B., Liao J., Liu J., Zhao Z. and Tan W., Development of Aptamer-Based Nanomaterials for Biological Analysis, Current Molecular Medicine 2013; 13 (4) . https://dx.doi.org/10.2174/1566524011313040016
DOI https://dx.doi.org/10.2174/1566524011313040016 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomic Approaches for the Study of Transgelins as Tumor-associated Proteins and Potential Biomarkers
Current Proteomics Two Promising Anti-Cancer Compounds, 2-Hydroxycinnaldehyde and 2- Benzoyloxycinnamaldehyde: Where do we stand?
Combinatorial Chemistry & High Throughput Screening Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine
Current Pharmaceutical Design The Enzymology of Cytosolic Pyrimidine 5’-Nucleotidases: Functional Analysis and Physiopathological Implications.
Current Medicinal Chemistry Medicinal and Cosmetic Potentials of Sophorolipids
Mini-Reviews in Medicinal Chemistry Evidence-Based Management of Infertile Couples with Repeated Implantation Failure Following IVF
Current Women`s Health Reviews Histone Deacetylase Inhibitors: A Review on Class-I Specific Inhibition
Mini-Reviews in Medicinal Chemistry Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders
Current Pharmaceutical Design The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Targeting Sphingosine-1-Phosphate in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Natural Products Chemistry in Marine Ascidians of the Genus Aplidium
Mini-Reviews in Organic Chemistry Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Current Topics in Medicinal Chemistry Relaxin-Like Peptides in Neoplastic Lesions
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Development of Arene Ruthenium Antitumor Complexes
Mini-Reviews in Medicinal Chemistry Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics
Current Pharmaceutical Design Signaling in Human B-Lymphoma Rafts
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Current Organic Chemistry Cell Hierarchy, Metabolic Flexibility and Systems Approaches to Cancer Treatment
Current Pharmaceutical Biotechnology Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design
Current Pharmaceutical Biotechnology